对公共卫生系统作为疫苗接种信息来源的信任在支持性环境中最重要
研究基于美国2549名成人的全国代表性样本,分析对CDC作为疫苗信息来源的信任、保险覆盖及医务人员讨论与2018-19流感季实际接种的关系。多层回归显示,信任对接种的促进作用仅见于有保险覆盖或医务人员讨论疫苗的受访者,两者同时存在时效应更强。支持性环境因素使信任对接种的正向影响提高近50%。
要点
- 对CDC作为疫苗信息来源的信任是接种的强预测因素,但该效应仅在有保险覆盖或医务人员讨论疫苗时出现。
- 保险覆盖与医务人员讨论同时存在时,信任对接种的促进作用更强。
- 支持性环境因素使信任对接种的正向影响提高近50%。
核心结论
- 支持疫苗接种的环境因素使对CDC信任对接种的正向影响提高近50%。
- 保险公司和医务人员可通过覆盖疫苗费用及与患者个性化讨论疫苗来促进接种。
研究设计与样本
- 研究采用美国全国代表性样本,共2549名成人,回答关于对CDC信任、保险覆盖、与医务人员互动及风险感知的问题,并提供2018-19流感季实际接种的纵向报告。
主要发现
- 对CDC作为疫苗信息来源的信任是接种的强预测因素。
- 多层回归显示,信任的效应仅局限于有保险覆盖或医务人员与其讨论疫苗的受访者。
- 当保险覆盖和医务人员讨论同时存在时,信任的效应更强。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To understand whether health insurance coverage of vaccine costs and discussing vaccination with a healthcare provider are necessary for trust in CDC (Centers for Disease Control) to increase the uptake of the vaccine. METHOD: A nationally representative sample of 2,549 adults from the United States answered questions about trust in CDC, insurance coverage, interactions with healthcare providers, and risk perceptions, and then provided longitudinal reports of actual vaccination against influenza during the course of the 2018-19 flu season. RESULTS: Trust in CDC as a source of information on vaccines was a strong precursor of vaccination. According to multilevel regressions, however, this effect was localized to respondents who had insurance coverage or whose providers discussed the vaccine with them. Further, the effect of trust was even stronger when both insurance coverage and healthcare provider discussions were present. CONCLUSIONS: Environmental factors supportive of vaccination increased the positive influence of trust in CDC on vaccine uptake by almost 50 percent. Insurance companies and healthcare providers can promote vaccination by covering the costs of vaccination and discussing vaccines in personalized conversations with patients.
引用
- Lohmann S, Albarracín D. Trust in the public health system as a source of information on vaccination matters most when environments are supportive. Vaccine. 2022. PMID: 35753840. doi:10.1016/j.vaccine.2022.06.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。